Expression of interleukin-32 in bone marrow of patients with myeloma and its prognostic significance
Gang Wang, Fang-Ying Ning, Jia-Heng Wang, Hai-Meng Yan, Hong-Wei Kong, Yu-Ting Zhang, Qiang Shen
Gang Wang, Jia-Heng Wang, Hong-Wei Kong, Department of Hematology, Quzhou People’s Hospital, Quzhou 324000, Zhejiang Province, China
Fang-Ying Ning, Department of Hematology, People’s Hospital of Hangzhou Medical College, Zhejiang Provincial People’s Hospital, Hangzhou 310000, Zhejiang Province, China
Hai-Meng Yan, Qiang Shen, Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang Province, China
Yu-Ting Zhang, Adicon Clinical Laboratories Inc., Hangzhou 310023, Zhejiang Province, China
Author contributions: Wang G and Ning FY contributed equally to this study; Wang G and Ning FY designed the research; Wang G, Ning FY, Kong HW, Zhang YT and Shen Q performed the research; Yan HM, Kong HW and Zhang YT analyzed the data; Wang G, Ning FY, Wang JH, Yan HM, Kong HW, Zhang YT and Shen Q wrote and revised the paper.
Supported by Foundation for Excellent Young Medical Talents from the Quzhou People's Hospital.
Institutional review board statement: The study was approved by the Ethics Committee of People’s Hospital of Hangzhou Medical College.
Informed consent statement: All patients included in this study gave informed consent.
Conflict-of-interest statement: There is no conflict of interest to declare.
Data sharing statement: No additional data are available.
STROBE statement: The manuscript was prepared and revised according to the STROBE statement.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Fang-Ying Ning, MD, Doctor, Department of Hematology, People’s Hospital of Hangzhou Medical College, Zhejiang Provincial People’s Hospital, No. 158 Shangtang Road, Xiacheng District, Hangzhou 310000, Zhejiang Province, China.
nfy182110@aliyun.com
Received: September 8, 2019
Peer-review started: September 8, 2019
First decision: November 11, 2019
Revised: October 14, 2019
Accepted: November 27, 2019
Article in press: November 27, 2019
Published online: December 26, 2019
Processing time: 108 Days and 6.1 Hours
